A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination.

MLA

Oliveira, Roberto Dias de, et al. “A Case Report on Symptomatic Disease Caused by Serotype 4 Vaccine Virus Following Tetravalent Anti-Dengue Vaccination.” Travel Medicine and Infectious Disease, vol. 62, Nov. 2024, p. 102782. EBSCOhost, https://doi.org/10.1016/j.tmaid.2024.102782.

APA

Oliveira, R. D. de, Santos, A. da S., Gonçalves, C. C. M., Giovanetti, M., Alcantara, L. C. J., Demarchi, L. H. F., Lichs, G. G. de C., Ilis, T. M., Hiane, S. T., Abbud, A., Sacchi, C. T., Naveca, F. G., Santos, D. de S., Marques, E. M. M., Lucena Junior, W. P. de, & Croda, J. (2024). A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination. Travel Medicine and Infectious Disease, 62, 102782. https://doi.org/10.1016/j.tmaid.2024.102782

Chicago

Oliveira, Roberto Dias de, Andrea da Silva Santos, Crhistinne Cavalheiro Maymone Gonçalves, Marta Giovanetti, Luiz Carlos Junior Alcantara, Luiz Henrique Ferraz Demarchi, Gislene Garcia de Castro Lichs, et al. 2024. “A Case Report on Symptomatic Disease Caused by Serotype 4 Vaccine Virus Following Tetravalent Anti-Dengue Vaccination.” Travel Medicine and Infectious Disease 62 (November): 102782. doi:10.1016/j.tmaid.2024.102782.